Introduction
Methods
Design and setting
Patient inclusion
Data extraction
Outcome measures
Statistical analysis
Results
Patient characteristics
Gender (women) | 2000 (55.4%)a |
Medication usedb | |
RAAS-inhibitors | 2301 (63.8%) |
Diuretics | 2005 (55.6%) |
NSAIDs | 1677 (46.5%) |
Combination of all drugs | 451 (12.5%) |
Risk factorsb | |
Chronic kidney disease | 1142 (31.7%) |
Heart Failure | 665 (18.4%) |
Age ≥ 70 | 3331 (92.3%) |
All risk factors | 286 (7.9%) |
Characteristics | All episodes (n = 816) |
---|---|
Number of individual patients | 562a |
Age of patients at first contact of episode | 79.4 (47–100)b |
Gender of patients c(women) | 333 (59.3%) |
Medication used during first contact of episodesd | |
RAAS-inhibitors | 590 (72.3%) |
Diuretics | 471 (57.7%) |
NSAIDs | 99 (12.1%) |
Combination of all drugs | 19 (2.3%) |
Most frequent RFEs | |
Diarrhoea (D11) | 312 (38.2%) |
Fever (A03) | 245 (30%) |
Vomiting (D10) | 156 (19.1%) |
Most frequent diagnoses | |
Diarrhoea (D11) | 173 (21.2%) |
Gastroenteritis (D73) | 133 (16.3%) |
Fever (A03) | 87 (10.7%) |
Risk factors of patients during first contact of episoded | |
Chronic kidney disease | 281 (34.4%) |
Heart Failure | 239 (29.3%) |
Age ≥ 70 | 728 (89.2%) |
All risk factors | 100 (12.3%) |